Trial Profile

Phase 4 Study of Mirtazapine in Functional Dyspepsia Patients With Weight Loss.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 15 Jul 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Mirtazapine (Primary)
Indications Non-ulcer dyspepsia
Focus Therapeutic Use

Most Recent Events

10 May 2021 This trial has been completed in Belgium, according to European Clinical Trials Database record. (2012-09-11).
21 May 2013 Results presented at the Digestive Disease Week 2013.
12 Nov 2010 Additional lead trial centre and investigator (Tack J), actual initiation date (September 2006) and planned end date (December 2011) identified as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com